▶ 調査レポート

世界の経口高分子製剤市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Oral Macromolecule Formulation Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の経口高分子製剤市場規模・現状・予測(2021年-2027年) / Global Oral Macromolecule Formulation Market Size, Status and Forecast 2021-2027 / QFJ1-5915資料のイメージです。• レポートコード:QFJ1-5915
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、95ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、経口高分子製剤の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(カプセル、錠剤、液体)、用途別市場規模(病院薬局、小売薬局、オンライン薬局、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・経口高分子製剤の市場動向
・企業の競争状況、市場シェア
・経口高分子製剤の種類別市場規模と予測2016-2027(カプセル、錠剤、液体)
・経口高分子製剤の用途別市場規模と予測2016-2027(病院薬局、小売薬局、オンライン薬局、その他)
・経口高分子製剤の北米市場規模2016-2027(アメリカ、カナダ)
・経口高分子製剤の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・経口高分子製剤のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・経口高分子製剤の中南米市場規模2016-2027(メキシコ、ブラジル)
・経口高分子製剤の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Wellchem、Allergan、Synergy Pharmaceuticals、Novo Nordisk A/S、Oramed、Biocon India、Diabetology、Catalent)
・結論

Market Analysis and Insights: Global Oral Macromolecule Formulation Market
The global Oral Macromolecule Formulation market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oral Macromolecule Formulation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oral Macromolecule Formulation market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oral Macromolecule Formulation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oral Macromolecule Formulation market.

Global Oral Macromolecule Formulation Scope and Market Size
Oral Macromolecule Formulation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Macromolecule Formulation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Capsule
Tablet
Liquid

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Wellchem
Allergan
Synergy Pharmaceuticals
Novo Nordisk A/S
Oramed
Biocon India
Diabetology
Catalent

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Macromolecule Formulation Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Liquid
1.3 Market by Application
1.3.1 Global Oral Macromolecule Formulation Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Oral Macromolecule Formulation Market Perspective (2016-2027)
2.2 Oral Macromolecule Formulation Growth Trends by Regions
2.2.1 Oral Macromolecule Formulation Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oral Macromolecule Formulation Historic Market Share by Regions (2016-2021)
2.2.3 Oral Macromolecule Formulation Forecasted Market Size by Regions (2022-2027)
2.3 Oral Macromolecule Formulation Industry Dynamic
2.3.1 Oral Macromolecule Formulation Market Trends
2.3.2 Oral Macromolecule Formulation Market Drivers
2.3.3 Oral Macromolecule Formulation Market Challenges
2.3.4 Oral Macromolecule Formulation Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Oral Macromolecule Formulation Players by Revenue
3.1.1 Global Top Oral Macromolecule Formulation Players by Revenue (2016-2021)
3.1.2 Global Oral Macromolecule Formulation Revenue Market Share by Players (2016-2021)
3.2 Global Oral Macromolecule Formulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oral Macromolecule Formulation Revenue
3.4 Global Oral Macromolecule Formulation Market Concentration Ratio
3.4.1 Global Oral Macromolecule Formulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Macromolecule Formulation Revenue in 2020
3.5 Oral Macromolecule Formulation Key Players Head office and Area Served
3.6 Key Players Oral Macromolecule Formulation Product Solution and Service
3.7 Date of Enter into Oral Macromolecule Formulation Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Macromolecule Formulation Breakdown Data by Type
4.1 Global Oral Macromolecule Formulation Historic Market Size by Type (2016-2021)
4.2 Global Oral Macromolecule Formulation Forecasted Market Size by Type (2022-2027)

5 Oral Macromolecule Formulation Breakdown Data by Application
5.1 Global Oral Macromolecule Formulation Historic Market Size by Application (2016-2021)
5.2 Global Oral Macromolecule Formulation Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Oral Macromolecule Formulation Market Size (2016-2027)
6.2 North America Oral Macromolecule Formulation Market Size by Type
6.2.1 North America Oral Macromolecule Formulation Market Size by Type (2016-2021)
6.2.2 North America Oral Macromolecule Formulation Market Size by Type (2022-2027)
6.2.3 North America Oral Macromolecule Formulation Market Size by Type (2016-2027)
6.3 North America Oral Macromolecule Formulation Market Size by Application
6.3.1 North America Oral Macromolecule Formulation Market Size by Application (2016-2021)
6.3.2 North America Oral Macromolecule Formulation Market Size by Application (2022-2027)
6.3.3 North America Oral Macromolecule Formulation Market Size by Application (2016-2027)
6.4 North America Oral Macromolecule Formulation Market Size by Country
6.4.1 North America Oral Macromolecule Formulation Market Size by Country (2016-2021)
6.4.2 North America Oral Macromolecule Formulation Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Oral Macromolecule Formulation Market Size (2016-2027)
7.2 Europe Oral Macromolecule Formulation Market Size by Type
7.2.1 Europe Oral Macromolecule Formulation Market Size by Type (2016-2021)
7.2.2 Europe Oral Macromolecule Formulation Market Size by Type (2022-2027)
7.2.3 Europe Oral Macromolecule Formulation Market Size by Type (2016-2027)
7.3 Europe Oral Macromolecule Formulation Market Size by Application
7.3.1 Europe Oral Macromolecule Formulation Market Size by Application (2016-2021)
7.3.2 Europe Oral Macromolecule Formulation Market Size by Application (2022-2027)
7.3.3 Europe Oral Macromolecule Formulation Market Size by Application (2016-2027)
7.4 Europe Oral Macromolecule Formulation Market Size by Country
7.4.1 Europe Oral Macromolecule Formulation Market Size by Country (2016-2021)
7.4.2 Europe Oral Macromolecule Formulation Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Oral Macromolecule Formulation Market Size (2016-2027)
8.2 Asia-Pacific Oral Macromolecule Formulation Market Size by Type
8.2.1 Asia-Pacific Oral Macromolecule Formulation Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oral Macromolecule Formulation Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oral Macromolecule Formulation Market Size by Type (2016-2027)
8.3 Asia-Pacific Oral Macromolecule Formulation Market Size by Application
8.3.1 Asia-Pacific Oral Macromolecule Formulation Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oral Macromolecule Formulation Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oral Macromolecule Formulation Market Size by Application (2016-2027)
8.4 Asia-Pacific Oral Macromolecule Formulation Market Size by Region
8.4.1 Asia-Pacific Oral Macromolecule Formulation Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oral Macromolecule Formulation Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Oral Macromolecule Formulation Market Size (2016-2027)
9.2 Latin America Oral Macromolecule Formulation Market Size by Type
9.2.1 Latin America Oral Macromolecule Formulation Market Size by Type (2016-2021)
9.2.2 Latin America Oral Macromolecule Formulation Market Size by Type (2022-2027)
9.2.3 Latin America Oral Macromolecule Formulation Market Size by Type (2016-2027)
9.3 Latin America Oral Macromolecule Formulation Market Size by Application
9.3.1 Latin America Oral Macromolecule Formulation Market Size by Application (2016-2021)
9.3.2 Latin America Oral Macromolecule Formulation Market Size by Application (2022-2027)
9.3.3 Latin America Oral Macromolecule Formulation Market Size by Application (2016-2027)
9.4 Latin America Oral Macromolecule Formulation Market Size by Country
9.4.1 Latin America Oral Macromolecule Formulation Market Size by Country (2016-2021)
9.4.2 Latin America Oral Macromolecule Formulation Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Oral Macromolecule Formulation Market Size (2016-2027)
10.2 Middle East & Africa Oral Macromolecule Formulation Market Size by Type
10.2.1 Middle East & Africa Oral Macromolecule Formulation Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oral Macromolecule Formulation Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oral Macromolecule Formulation Market Size by Type (2016-2027)
10.3 Middle East & Africa Oral Macromolecule Formulation Market Size by Application
10.3.1 Middle East & Africa Oral Macromolecule Formulation Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oral Macromolecule Formulation Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oral Macromolecule Formulation Market Size by Application (2016-2027)
10.4 Middle East & Africa Oral Macromolecule Formulation Market Size by Country
10.4.1 Middle East & Africa Oral Macromolecule Formulation Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oral Macromolecule Formulation Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Wellchem
11.1.1 Wellchem Company Details
11.1.2 Wellchem Business Overview
11.1.3 Wellchem Oral Macromolecule Formulation Introduction
11.1.4 Wellchem Revenue in Oral Macromolecule Formulation Business (2016-2021)
11.1.5 Wellchem Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Oral Macromolecule Formulation Introduction
11.2.4 Allergan Revenue in Oral Macromolecule Formulation Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Synergy Pharmaceuticals
11.3.1 Synergy Pharmaceuticals Company Details
11.3.2 Synergy Pharmaceuticals Business Overview
11.3.3 Synergy Pharmaceuticals Oral Macromolecule Formulation Introduction
11.3.4 Synergy Pharmaceuticals Revenue in Oral Macromolecule Formulation Business (2016-2021)
11.3.5 Synergy Pharmaceuticals Recent Development
11.4 Novo Nordisk A/S
11.4.1 Novo Nordisk A/S Company Details
11.4.2 Novo Nordisk A/S Business Overview
11.4.3 Novo Nordisk A/S Oral Macromolecule Formulation Introduction
11.4.4 Novo Nordisk A/S Revenue in Oral Macromolecule Formulation Business (2016-2021)
11.4.5 Novo Nordisk A/S Recent Development
11.5 Oramed
11.5.1 Oramed Company Details
11.5.2 Oramed Business Overview
11.5.3 Oramed Oral Macromolecule Formulation Introduction
11.5.4 Oramed Revenue in Oral Macromolecule Formulation Business (2016-2021)
11.5.5 Oramed Recent Development
11.6 Biocon India
11.6.1 Biocon India Company Details
11.6.2 Biocon India Business Overview
11.6.3 Biocon India Oral Macromolecule Formulation Introduction
11.6.4 Biocon India Revenue in Oral Macromolecule Formulation Business (2016-2021)
11.6.5 Biocon India Recent Development
11.7 Diabetology
11.7.1 Diabetology Company Details
11.7.2 Diabetology Business Overview
11.7.3 Diabetology Oral Macromolecule Formulation Introduction
11.7.4 Diabetology Revenue in Oral Macromolecule Formulation Business (2016-2021)
11.7.5 Diabetology Recent Development
11.8 Catalent
11.8.1 Catalent Company Details
11.8.2 Catalent Business Overview
11.8.3 Catalent Oral Macromolecule Formulation Introduction
11.8.4 Catalent Revenue in Oral Macromolecule Formulation Business (2016-2021)
11.8.5 Catalent Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Oral Macromolecule Formulation Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Capsule
Table 3. Key Players of Tablet
Table 4. Key Players of Liquid
Table 5. Global Oral Macromolecule Formulation Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Oral Macromolecule Formulation Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Oral Macromolecule Formulation Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Oral Macromolecule Formulation Market Share by Regions (2016-2021)
Table 9. Global Oral Macromolecule Formulation Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Oral Macromolecule Formulation Market Share by Regions (2022-2027)
Table 11. Oral Macromolecule Formulation Market Trends
Table 12. Oral Macromolecule Formulation Market Drivers
Table 13. Oral Macromolecule Formulation Market Challenges
Table 14. Oral Macromolecule Formulation Market Restraints
Table 15. Global Oral Macromolecule Formulation Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Oral Macromolecule Formulation Market Share by Players (2016-2021)
Table 17. Global Top Oral Macromolecule Formulation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Macromolecule Formulation as of 2020)
Table 18. Ranking of Global Top Oral Macromolecule Formulation Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Oral Macromolecule Formulation Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oral Macromolecule Formulation Product Solution and Service
Table 22. Date of Enter into Oral Macromolecule Formulation Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oral Macromolecule Formulation Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Oral Macromolecule Formulation Revenue Market Share by Type (2016-2021)
Table 26. Global Oral Macromolecule Formulation Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Oral Macromolecule Formulation Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Oral Macromolecule Formulation Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Oral Macromolecule Formulation Revenue Market Share by Application (2016-2021)
Table 30. Global Oral Macromolecule Formulation Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Oral Macromolecule Formulation Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Oral Macromolecule Formulation Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Oral Macromolecule Formulation Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Oral Macromolecule Formulation Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Oral Macromolecule Formulation Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Oral Macromolecule Formulation Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Oral Macromolecule Formulation Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Oral Macromolecule Formulation Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Oral Macromolecule Formulation Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Oral Macromolecule Formulation Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Oral Macromolecule Formulation Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Oral Macromolecule Formulation Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Oral Macromolecule Formulation Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Oral Macromolecule Formulation Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Oral Macromolecule Formulation Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Oral Macromolecule Formulation Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Oral Macromolecule Formulation Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Oral Macromolecule Formulation Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Oral Macromolecule Formulation Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Oral Macromolecule Formulation Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Oral Macromolecule Formulation Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Oral Macromolecule Formulation Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Oral Macromolecule Formulation Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Oral Macromolecule Formulation Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Oral Macromolecule Formulation Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Oral Macromolecule Formulation Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Oral Macromolecule Formulation Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Oral Macromolecule Formulation Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Oral Macromolecule Formulation Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Oral Macromolecule Formulation Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Oral Macromolecule Formulation Market Size by Country (2022-2027) & (US$ Million)
Table 62. Wellchem Company Details
Table 63. Wellchem Business Overview
Table 64. Wellchem Oral Macromolecule Formulation Product
Table 65. Wellchem Revenue in Oral Macromolecule Formulation Business (2016-2021) & (US$ Million)
Table 66. Wellchem Recent Development
Table 67. Allergan Company Details
Table 68. Allergan Business Overview
Table 69. Allergan Oral Macromolecule Formulation Product
Table 70. Allergan Revenue in Oral Macromolecule Formulation Business (2016-2021) & (US$ Million)
Table 71. Allergan Recent Development
Table 72. Synergy Pharmaceuticals Company Details
Table 73. Synergy Pharmaceuticals Business Overview
Table 74. Synergy Pharmaceuticals Oral Macromolecule Formulation Product
Table 75. Synergy Pharmaceuticals Revenue in Oral Macromolecule Formulation Business (2016-2021) & (US$ Million)
Table 76. Synergy Pharmaceuticals Recent Development
Table 77. Novo Nordisk A/S Company Details
Table 78. Novo Nordisk A/S Business Overview
Table 79. Novo Nordisk A/S Oral Macromolecule Formulation Product
Table 80. Novo Nordisk A/S Revenue in Oral Macromolecule Formulation Business (2016-2021) & (US$ Million)
Table 81. Novo Nordisk A/S Recent Development
Table 82. Oramed Company Details
Table 83. Oramed Business Overview
Table 84. Oramed Oral Macromolecule Formulation Product
Table 85. Oramed Revenue in Oral Macromolecule Formulation Business (2016-2021) & (US$ Million)
Table 86. Oramed Recent Development
Table 87. Biocon India Company Details
Table 88. Biocon India Business Overview
Table 89. Biocon India Oral Macromolecule Formulation Product
Table 90. Biocon India Revenue in Oral Macromolecule Formulation Business (2016-2021) & (US$ Million)
Table 91. Biocon India Recent Development
Table 92. Diabetology Company Details
Table 93. Diabetology Business Overview
Table 94. Diabetology Oral Macromolecule Formulation Product
Table 95. Diabetology Revenue in Oral Macromolecule Formulation Business (2016-2021) & (US$ Million)
Table 96. Diabetology Recent Development
Table 97. Catalent Company Details
Table 98. Catalent Business Overview
Table 99. Catalent Revenue in Oral Macromolecule Formulation Business (2016-2021) & (US$ Million)
Table 100. Catalent Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Macromolecule Formulation Market Share by Type: 2020 VS 2027
Figure 2. Capsule Features
Figure 3. Tablet Features
Figure 4. Liquid Features
Figure 5. Global Oral Macromolecule Formulation Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Others Case Studies
Figure 10. Oral Macromolecule Formulation Report Years Considered
Figure 11. Global Oral Macromolecule Formulation Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Oral Macromolecule Formulation Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Oral Macromolecule Formulation Market Share by Regions: 2020 VS 2027
Figure 14. Global Oral Macromolecule Formulation Market Share by Regions (2022-2027)
Figure 15. Global Oral Macromolecule Formulation Market Share by Players in 2020
Figure 16. Global Top Oral Macromolecule Formulation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Macromolecule Formulation as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Oral Macromolecule Formulation Revenue in 2020
Figure 18. Global Oral Macromolecule Formulation Revenue Market Share by Type (2016-2021)
Figure 19. Global Oral Macromolecule Formulation Revenue Market Share by Type (2022-2027)
Figure 20. North America Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Oral Macromolecule Formulation Market Share by Type (2016-2027)
Figure 22. North America Oral Macromolecule Formulation Market Share by Application (2016-2027)
Figure 23. North America Oral Macromolecule Formulation Market Share by Country (2016-2027)
Figure 24. United States Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Oral Macromolecule Formulation Market Share by Type (2016-2027)
Figure 28. Europe Oral Macromolecule Formulation Market Share by Application (2016-2027)
Figure 29. Europe Oral Macromolecule Formulation Market Share by Country (2016-2027)
Figure 30. Germany Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Oral Macromolecule Formulation Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Oral Macromolecule Formulation Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Oral Macromolecule Formulation Market Share by Region (2016-2027)
Figure 40. China Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Oral Macromolecule Formulation Market Share by Type (2016-2027)
Figure 48. Latin America Oral Macromolecule Formulation Market Share by Application (2016-2027)
Figure 49. Latin America Oral Macromolecule Formulation Market Share by Country (2016-2027)
Figure 50. Mexico Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Oral Macromolecule Formulation Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Oral Macromolecule Formulation Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Oral Macromolecule Formulation Market Share by Country (2016-2027)
Figure 56. Turkey Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Oral Macromolecule Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Wellchem Revenue Growth Rate in Oral Macromolecule Formulation Business (2016-2021)
Figure 60. Allergan Revenue Growth Rate in Oral Macromolecule Formulation Business (2016-2021)
Figure 61. Synergy Pharmaceuticals Revenue Growth Rate in Oral Macromolecule Formulation Business (2016-2021)
Figure 62. Novo Nordisk A/S Revenue Growth Rate in Oral Macromolecule Formulation Business (2016-2021)
Figure 63. Oramed Revenue Growth Rate in Oral Macromolecule Formulation Business (2016-2021)
Figure 64. Biocon India Revenue Growth Rate in Oral Macromolecule Formulation Business (2016-2021)
Figure 65. Diabetology Revenue Growth Rate in Oral Macromolecule Formulation Business (2016-2021)
Figure 66. Catalent Revenue Growth Rate in Oral Macromolecule Formulation Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed